Company Profile

Beijing Kawin Technology Share-Holding Co. Ltd
Year Established : 2008
Main Competitive Advantages : Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Reputation,Quality Service
  • Contact Person :
  • Fax:
Focusing on viral and immune diseases, Kawin can offer matured products based upon our specialty in interferon strain management, in EP standard. We also can provide product licensing opportunities like our portfolio of Glycyrrhizin products that have been popularized in dermatology and hepatology. Transfer of Interferon & GCSF (both conventional & pegylated), and kinds of mAbs (Nivolumab) are also open to discussion.
Certificates/Standards
PharmaSources Customer Service